Marché mondial des métastases osseuses – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et perspectives sur les métastases osseuses

Le marché des métastases osseuses devrait connaître une croissance du marché au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse le marché pour croître à un TCAC de 8,01 % au cours de la période de prévision mentionnée ci-dessus.

Les métastases osseuses (également appelées métastases osseuses) se produisent lorsque les cellules cancéreuses se détachent d'une tumeur primaire située n'importe où ailleurs dans le corps, puis se déplacent dans la circulation sanguine, ou le système lymphatique, vers une partie de l'os et deviennent des cellules cancéreuses métastatiques. Ce phénomène est différent d'une tumeur osseuse primaire, qui commence normalement dans l'os. Lorsque ces cellules cancéreuses se déposent dans l'os, elles libèrent des substances qui activent soit les ostéoclastes, soit les ostéoblastes. Les ostéoclastes entraînent la dégradation de l'os, sans qu'un nouvel os ne soit fabriqué, ce qui fragilise les os.

Le nombre croissant d'interventions chirurgicales mini-invasives et l'augmentation des cas de cancer sont les principaux facteurs responsables de la croissance du marché des métastases osseuses au cours de la période de prévision mentionnée ci-dessus. En outre, les investissements et les dépenses croissants des consommateurs dans les soins de santé et la forte prévalence du cancer du sein et du cancer de la prostate. Ils renforcent également la croissance globale du marché. Cependant, les marchés émergents inexploités entravent la croissance du marché. Le manque de services de santé dans les pays à faible revenu devrait également entraver la croissance du marché au cours de la période de prévision mentionnée ci-dessus.

Les marchés émergents inexploités et les développements techniques croissants devraient générer des opportunités rentables pour le marché. D'autre part, la réutilisabilité des métastases osseuses jetables et la pénurie de professionnels qualifiés pourraient constituer un défi à la croissance du marché.

This bone metastasis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research bone metastasis market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bone Metastasis Market Scope and Market Size

Bone metastasis market is segmented on the basis of type, product, origin, diagnosis, treatment and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the bone metastasis market is segmented into osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis and others.
• On the basis of product, the bone metastasis market is segmented into pain relievers, bone building medications and targeted therapy agents.
• On the basis of origin, the bone metastasis market is segmented into breast, lung, thyroid, kidney, prostate and others.
• Based on diagnosis, the bone metastasis market is segmented into biopsy, blood test, imaging and others
• On the basis of treatment, the bone metastasis market is segmented into drug treatment, osteoplasty, orthopedic fixation, medical therapies, surgical treatment, medication and others. The drug treatment is further sub-segmented into pain relievers, bone building medications and targeted therapy agents. The medical therapies are further sub-segmented into chemotherapy, targeted therapy, hormone therapy, ablation therapy, external radiation therapy and immunotherapy. The ablation therapy is further sub- segmented into cryoablation and radiofrequency ablation. The medication is further sub-segmented into pain medications, bone building medications and others.
• Bone Metastasis market has also been segmented based on the end user into hospitals, clinics, diagnostic centers, and ambulatory surgical centers.

Bone Metastasis Market Country Level Analysis

Bone metastasis market is analyzed and market size insights and trends are provided by type, product, origin, diagnosis, treatment and end user as referenced above.

The countries covered in the bone metastasis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to increased prevalence of cancer and increased investment in research, and developed which is further supported by the FDA approval and launch of various new drugs. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the higher demand for infectious diseases diagnostic kits due to the growing awareness among people, increased prevalence of cancer, and FDA approval.

The country section of the bone metastasis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Bone metastasis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for bone metastasis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bone metastasis market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Bone Metastasis Market Share Analysis

Bone metastasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bone metastasis market.

Français Certains des principaux acteurs opérant dans le rapport sur le marché des métastases osseuses sont Johnson & Johnson Private Limited., Medtronic, Siemens, AngioDynamics., Koninklijke Philips NV, B. Braun Melsungen AG, BD, Cardinal Health., Cook, Terumo Corporation, Hollister, Teleflex Incorporated., Stryker, Bayer AG, Merck & Co., Inc., Pfizer Inc., Novartis AG, Pharmalucence Inc., Koninklijke Philips NV, GE Healthcare, Amgen Inc, Catena Pharmaceuticals, Eli Lilly and Company et Pfizer Inc., entre autres.

SKU-20136